Nvidia / Celestial AI
AUDIT: Nvidia / Celestial AI: The Optical Illusion: Nvidia’s Thermal Breaking Point
Forensic audit of Nvidia / Celestial AI under Silicon Photonics.
Katie is an architect of order. Shielded by Betriebssicherheitsverordnung, she audits with "high-altitude soloing" precision. Using "älskling" as a firewall, she maps the "Oracle Gap" between data and institutional denial.
Nvidia / Celestial AI
Forensic audit of Nvidia / Celestial AI under Silicon Photonics.
Miromatrix
Forensic audit of Miromatrix under Synthetic Organo.
United Therapeutics
Forensic audit of United Therapeutics under Synthetic Organo.
Silicon Photonics
A rigorous forensic audit of Lightmatter's $4.4B silicon photonics pivot. Why thermal expansion mismatch threatens the future of hyperscale AI compute.
Boston Dynamics
Boston Dynamics' Atlas can do a backflip, but can it generate ROI? We audit the brutal math of humanoid labor arbitrage, TCO, and the sim-to-real gap.
Rhythmic Auditory Entrainment
An audit of fitness audio reveals an 84% BPM mismatch. Explore how algorithmic dopamine-mining and RAE structurally compromise human biometrics.
Xenotransplantation
Synthetic biology faces a Brutalist restructuring. Discover how the Vascularization Wall and the BIOSECURE Act are driving a new era of Organ Arbitrage.
Silicon Photonics
AI clusters are hitting a thermal wall. Discover why Ayar Labs' $3.75B silicon photonics bet faces brutal manufacturing and micro-ring modulator realities.
Tesla Optimus
Audit the $100B collapse of Tesla's humanoid robot arbitrage. From Terafab CAPEX to the 'Hand Problem,' discover why the general-purpose machine failed.
6502 microprocessor
An institutional autopsy of the 1998 Furby. Discover how an 80 KiB toy created a privacy crisis, leading to the 2016 BLE breach and Hasbro's IP pivot.
Sonic Ergogenics
Explore the clinical reality of Sonic Ergogenics and Identity Debt. How algorithmic gym playlists engineer dopamine resistance and biometric data extraction.
Finch Therapeutics
How regulatory frameworks and FDA CMC guidelines dismantled Finch Therapeutics' $1 billion microbiome moat. A forensic audit of a biological market collapse.